As the global economy mends, the 2021 growth of Brain Tumor Diagnostics and Therapeutics will have significant change from previous year. According to our (LP Information) latest study, the global Brain Tumor Diagnostics and Therapeutics market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Brain Tumor Diagnostics and Therapeutics market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Brain Tumor Diagnostics and Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Brain Tumor Diagnostics and Therapeutics market, reaching US$ million by the year 2028. As for the Europe Brain Tumor Diagnostics and Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Brain Tumor Diagnostics and Therapeutics players cover Pfizer, Novartis, Roche, and Merck, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Brain Tumor Diagnostics and Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Surgery
Radiation Therapy
Targeted Therapy
Chemotherapy
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals and Cancer Center
Oncology Treatment Centers
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer
Novartis
Roche
Merck
Curtana Pharmaceuticals
GE Healthcare
Hitachi Medical
Philips Healthcare
Novocure
AbbVie
Daiichi Sankyo
Genetech
Carthera
EMulate Therapeutics